4.56
price down icon7.69%   -0.38
pre-market  시장 영업 전:  4.37   -0.19   -4.17%
loading
전일 마감가:
$4.94
열려 있는:
$4.94
하루 거래량:
2.97M
Relative Volume:
0.79
시가총액:
$613.66M
수익:
-
순이익/손실:
$-217.44M
주가수익비율:
-2.1014
EPS:
-2.17
순현금흐름:
$-205.20M
1주 성능:
-11.46%
1개월 성능:
-27.85%
6개월 성능:
+171.43%
1년 성능:
+13.15%
1일 변동 폭
Value
$4.45
$4.98
1주일 범위
Value
$4.31
$5.11
52주 변동 폭
Value
$1.11
$6.94

Prime Medicine Inc Stock (PRME) Company Profile

Name
명칭
Prime Medicine Inc
Name
전화
617-465-0013
Name
주소
60 FIRST ST., CAMBRIDGE
Name
직원
214
Name
트위터
Name
다음 수익 날짜
2025-10-31
Name
최신 SEC 제출 서류
Name
PRME's Discussions on Twitter

PRME을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PRME
Prime Medicine Inc
4.56 880.67M 0 -217.44M -205.20M -2.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Prime Medicine Inc Stock (PRME) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-27 다운그레이드 Citigroup Buy → Neutral
2025-05-20 다운그레이드 H.C. Wainwright Buy → Neutral
2025-05-20 다운그레이드 JP Morgan Overweight → Neutral
2024-12-10 개시 JMP Securities Mkt Outperform
2024-05-20 개시 H.C. Wainwright Buy
2024-05-16 업그레이드 Citigroup Neutral → Buy
2024-04-22 개시 Chardan Capital Markets Buy
2024-04-08 개시 TD Cowen Buy
2024-04-03 개시 Wedbush Outperform
2024-01-16 다운그레이드 Stifel Buy → Hold
2023-12-08 개시 Citigroup Neutral
2023-10-09 개시 BMO Capital Markets Outperform
2023-07-31 개시 Guggenheim Buy
2023-04-18 개시 Stifel Buy
2022-11-14 개시 Goldman Neutral
2022-11-14 개시 JP Morgan Overweight
2022-11-14 개시 Jefferies Buy
2022-11-14 개시 Morgan Stanley Equal-Weight
모두보기

Prime Medicine Inc 주식(PRME)의 최신 뉴스

pulisher
06:28 AM

Levin Capital Strategies L.P. Increases Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat

06:28 AM
pulisher
02:16 AM

Tick level data insight on Prime Medicine Inc. volatilityGold Moves & Daily Entry Point Alerts - newser.com

02:16 AM
pulisher
01:35 AM

Is Prime Medicine Inc. stock a buy in volatile markets2025 Growth vs Value & Consistent Income Trade Recommendations - newser.com

01:35 AM
pulisher
Nov 03, 2025

Prime Medicine appoints Matthew Hawryluk as chief business officer By Investing.com - Investing.com Nigeria

Nov 03, 2025
pulisher
Nov 03, 2025

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer - citybiz

Nov 03, 2025
pulisher
Nov 03, 2025

Prime Medicine (PRME) Competitors and Alternatives 2025 - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

How institutional ownership impacts Prime Medicine Inc. stock2025 Stock Rankings & Smart Money Movement Tracker - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Prime Medicine appoints Matthew Hawryluk as chief business officer - Investing.com

Nov 03, 2025
pulisher
Nov 03, 2025

Prime Medicine, Inc. Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer - Quiver Quantitative

Nov 03, 2025
pulisher
Nov 03, 2025

Prime Medicine (NASDAQ: PRME) names Matthew Hawryluk CBO; >$2.5B in deals at Gritstone - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Why Prime Medicine Inc. stock appeals to analystsMarket Movement Recap & Weekly Market Pulse Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Prime Medicine Inc. stock outperform growth indexesMarket Growth Report & Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Smart tools for monitoring Prime Medicine Inc.’s price actionWeekly Investment Summary & Fast Exit and Entry Strategy Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Price momentum metrics for Prime Medicine Inc. explainedMarket Risk Summary & Daily Market Momentum Tracking - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Prime Medicine Inc. stock supported by strong fundamentalsJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Prime Medicine Inc. stock reacts to job market data2025 Momentum Check & Expert Curated Trade Setup Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How Prime Medicine Inc. stock performs in weak economyJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Combining price and volume data for Prime Medicine Inc.Buy Signal & Technical Pattern Based Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Momentum divergence signals in Prime Medicine Inc. chartMarket Trend Summary & Verified Swing Trading Watchlists - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Comparing Prime Medicine Inc. in custom built stock radarsJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Technical signs of recovery in Prime Medicine Inc.Market Risk Summary & Technical Confirmation Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine’s Price Target Revision Sparks Market Interest - StocksToTrade

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine Eyes Expansion with Strategic Partnerships and Investor Engagement - timothysykes.com

Nov 02, 2025
pulisher
Nov 02, 2025

Prime Medicine, Inc. (NYSE:PRME) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Prime Medicine’s Investor Activities and Upcoming Developments Boost Market Interest - StocksToTrade

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine Stock Poised for Strategic Growth With New Developments - timothysykes.com

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine (NASDAQ:PRME) Shares Up 9.9%Time to Buy? - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Prime Medicine (NYSE:PRME) Trading 11.9% HigherWhat's Next? - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Sumitomo Mitsui Trust Group Inc. Has $3.94 Million Position in Prime Medicine, Inc. $PRME - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

PRME Stock Surge: A Buying Opportunity? - StocksToTrade

Oct 31, 2025
pulisher
Oct 31, 2025

Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$174m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Does Prime Medicine Inc. qualify in momentum factor screeningEarnings Beat & Weekly High Potential Stock Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using economic indicators to assess Prime Medicine Inc. potentialWeekly Profit Report & AI Based Buy and Sell Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Reduces Stock Holdings in Prime Medicine, Inc. $PRME - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 03:29:26 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Can Prime Medicine Inc. stock outperform in 2025 bull marketTrend Reversal & Daily Technical Forecast Reports - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Prime Medicine (NASDAQ: PRME) to file IND/CTA for PM577 in H1 2026 for Wilson’s Disease - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today - MSN

Oct 30, 2025

Prime Medicine Inc (PRME) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Prime Medicine Inc 주식 (PRME) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
NELSEN ROBERT
Director
Aug 01 '25
Buy
3.30
3,030,300
9,999,990
6,230,300
ARCH Venture Partners XII, LLC
10% Owner
Aug 01 '25
Buy
3.30
3,030,300
9,999,990
6,230,300
ARCH Venture Partners X, LLC
10% Owner
Aug 01 '25
Buy
3.30
3,030,300
9,999,990
6,230,300
Liu David R.
10% Owner
Jun 30 '25
Buy
2.52
21,000
52,830
20,240,945
Liu David R.
10% Owner
Jun 23 '25
Buy
2.16
21,000
45,402
20,219,945
Liu David R.
10% Owner
Jun 16 '25
Buy
1.49
21,000
31,196
20,198,945
Liu David R.
10% Owner
Jun 11 '25
Buy
1.60
21,000
33,590
20,177,945
Brudnick Richard
Chief Business Officer
May 20 '25
Buy
1.19
20,000
23,790
20,000
LEE ANN L.
Chief Technical Officer
May 21 '25
Buy
1.13
100,000
113,000
100,000
Reine Allan
Chief Executive Officer
May 21 '25
Buy
1.18
125,000
147,150
125,000
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
자본화:     |  볼륨(24시간):